Clinical Trial Update: Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the PET radiotracer IAZGP (124I-iodo-azomycin galacto-pyranoside) for imaging hypoxic tumors; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Head and Neck Cancer
• Rectal Cancer
• Renal Cancer
• Uterine Cancer

Drugs mentioned

• IAZGP (124I-Iodo-Azomycin Galacto-Pyranoside) (IAZGP)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Cervical Cancer, HEENT Cancer | Phase 1 | Status: COMPLETED